Sendero Wealth Management LLC bought a new position in MercadoLibre, Inc. (NASDAQ:MELI – Free Report) in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The firm bought 452 shares of the company’s stock, valued at approximately $910,000. A number of other hedge funds have also added to […]

Sendero Wealth Management LLC lowered its position in shares of IQVIA Holdings Inc. (NYSE:IQV – Free Report) by 7.3% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 47,403 shares of the medical research company’s stock after selling 3,733 shares during the […]

Synergy Asset Management LLC purchased a new stake in shares of MercadoLibre, Inc. (NASDAQ:MELI – Free Report) in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm purchased 5,195 shares of the company’s stock, valued at approximately $10,464,000. MercadoLibre comprises about 1.1% of Synergy Asset […]

Synergy Asset Management LLC acquired a new stake in Duke Energy Corporation (NYSE:DUK – Free Report) during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor acquired 41,282 shares of the utilities provider’s stock, valued at approximately $4,839,000. Several other hedge funds and […]

Sendero Wealth Management LLC bought a new position in shares of Targa Resources, Inc. (NYSE:TRGP – Free Report) during the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor bought 21,953 shares of the pipeline company’s stock, valued at approximately $4,050,000. A number of other large investors […]

National Wealth Management Group LLC bought a new stake in shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX – Free Report) in the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund bought 1,529 shares of the pharmaceutical company’s stock, valued at approximately $693,000. Other hedge funds also recently […]